CYTEK BIOSCI (CTKB)
$4.03
0.11 (2.73%)
CTKB Stock Quote Delayed 30 Minutes
CTKB Stock Earnings: Cytek Biosciences Misses EPS, Misses Revenue for Q2 2024
CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$4.01
Market Cap
513.67M
PE Ratio
-87.42
EPS
-0.0461
Volume (Avg. Vol.)
1.18M
Day's Range
$3.90 - $4.04
52-Week Range
$3.90 - $7.63
Dividend & Yield
N/A (N/A)
